Design Therapeutics Inc (DSGN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $670.46M
Last updated: Nov 17, 2026 at 11:03 AM ET
Design Therapeutics Inc (DSGN) Earnings: Report Dates and Results
Design Therapeutics (DSGN) is expected to report earnings on Mar 8, 2027. In the quarter ended Sep 30, 2026, Design Therapeutics reported EPS of -$0.32, above the -$0.38 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
DSGN has an expected report date of Mar 8, 2027.
Earnings History
Of the 23 quarters below that had an estimate, DSGN beat 15, missed 7 and matched 1. The widest gap in the table came in the quarter ended Mar 31, 2021, when EPS landed 244.44% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.32 | -$0.38 | -$0.39 - -$0.30 | +15.79% | Beat | N/A | 8 | 2 up, 1 down | Nov 4, 2026 |
| Jun 30, 2026 | -$0.32 | -$0.36 | -$0.46 - -$0.29 | +11.11% | Beat | N/A | 7 | 3 up, 1 down | Aug 3, 2026 |
| Mar 31, 2026 | -$0.29 | -$0.33 | -$0.46 - -$0.29 | +12.12% | Beat | N/A | 5 | 3 up, 1 down | Apr 28, 2026 |
| Dec 31, 2025 | -$0.27 | -$0.33 | -$0.45 - -$0.30 | +18.18% | Beat | N/A | 5 | 1 up, 0 down | Mar 9, 2026 |
| Sep 30, 2025 | -$0.30 | -$0.34 | -$0.35 - -$0.33 | +11.76% | Beat | N/A | 3 | 1 up, 2 down | Nov 5, 2025 |
| Jun 30, 2025 | -$0.34 | -$0.32 | -$0.35 - -$0.31 | -6.25% | Miss | N/A | 3 | 0 up, 2 down | Aug 7, 2025 |
| Mar 31, 2025 | -$0.31 | -$0.28 | -$0.30 - -$0.26 | -10.71% | Miss | N/A | 3 | 1 up, 0 down | May 7, 2025 |
| Dec 31, 2024 | -$0.24 | -$0.27 | -$0.30 - -$0.25 | +10.01% | Beat | N/A | 3 | 0 up, 1 down | Mar 10, 2025 |
| Sep 30, 2024 | -$0.23 | -$0.24 | -$0.29 - -$0.21 | +4.17% | Beat | N/A | 3 | 0 up, 0 down | Nov 7, 2024 |
| Jun 30, 2024 | -$0.21 | -$0.23 | -$0.28 - -$0.20 | +8.70% | Beat | N/A | 3 | 0 up, 0 down | Aug 5, 2024 |
| Mar 31, 2024 | -$0.20 | -$0.26 | -$0.31 - -$0.23 | +23.08% | Beat | N/A | 3 | 0 up, 0 down | May 8, 2024 |
| Dec 31, 2023 | -$0.21 | -$0.31 | -$0.38 - -$0.28 | +32.26% | Beat | N/A | 4 | 0 up, 0 down | Mar 19, 2024 |
| Sep 30, 2023 | -$0.28 | -$0.42 | -$0.45 - -$0.37 | +33.33% | Beat | N/A | 4 | 0 up, 0 down | Nov 13, 2023 |
| Jun 30, 2023 | -$0.36 | -$0.40 | -$0.43 - -$0.36 | +10.00% | Beat | N/A | 4 | 0 up, 0 down | Aug 14, 2023 |
| Mar 31, 2023 | -$0.35 | -$0.35 | -$0.38 - -$0.32 | 0.00% | In line | N/A | 4 | 0 up, 0 down | May 9, 2023 |
| Dec 31, 2022 | -$0.31 | -$0.34 | -$0.38 - -$0.31 | +8.82% | Beat | N/A | 5 | 0 up, 0 down | Mar 14, 2023 |
| Sep 30, 2022 | -$0.32 | -$0.29 | -$0.32 - -$0.29 | -10.34% | Miss | N/A | 5 | 0 up, 2 down | Nov 3, 2022 |
| Jun 30, 2022 | -$0.27 | -$0.25 | -$0.26 - -$0.24 | -8.00% | Miss | N/A | 4 | 0 up, 0 down | Aug 8, 2022 |
| Mar 31, 2022 | -$0.24 | -$0.22 | -$0.24 - -$0.22 | -9.09% | Miss | N/A | 4 | 0 up, 1 down | May 9, 2022 |
| Dec 31, 2021 | -$0.20 | -$0.23 | -$0.25 - -$0.21 | +13.04% | Beat | N/A | 3 | N/A | Mar 10, 2022 |
| Sep 30, 2021 | -$0.21 | -$0.13 | -$0.20 - -$0.13 | -61.54% | Miss | N/A | 3 | 1 up, 0 down | Nov 9, 2021 |
| Jun 30, 2021 | -$0.14 | -$0.22 | -$0.26 - -$0.11 | +36.36% | Beat | N/A | 3 | N/A | Aug 9, 2021 |
| Mar 31, 2021 | -$0.31 | -$0.09 | -$0.09 - -$0.05 | -244.44% | Miss | N/A | 3 | N/A | May 10, 2021 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.22, after -$0.88 the year before. It was -$0.86 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.22 | N/A |
| Dec 31, 2024 | -$0.88 | N/A |
| Dec 31, 2023 | -$1.20 | N/A |
| Dec 31, 2022 | -$1.14 | N/A |
| Dec 31, 2021 | -$0.86 | N/A |
Frequently Asked Questions About DSGN
When is Design Therapeutics's next earnings date?
Design Therapeutics's next earnings report is expected for Mar 8, 2027.
Did DSGN beat earnings estimates last quarter?
Yes. Design Therapeutics reported EPS of -$0.32 for the quarter ended Sep 30, 2026, above the -$0.38 estimate, a 15.79% surprise.
What EPS do analysts expect from DSGN next quarter?
The consensus EPS estimate for Design Therapeutics for the quarter ending Dec 31, 2026 is -$0.40 from 10 analysts, with estimates from -$0.61 to -$0.30.
How often does DSGN beat earnings estimates?
Design Therapeutics beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +7.75%.
DSGN pages: Overview, Earnings, Forecast, Financials, Competitors